Studies on the relationship between chronic fatigue syndrome and Epstein-Barr virus in Japan.
Kawai, K, Kawai, A · Internal medicine (Tokyo, Japan) · 1992 · DOI
Quick Summary
This study examined whether Epstein-Barr virus (EBV), a common virus that causes infectious mononucleosis, might be connected to chronic fatigue syndrome (CFS). Researchers tested 22 patients with long-lasting fatigue and found that those with definite CFS had higher levels of certain EBV antibodies compared to patients with milder symptoms and healthy controls. The study suggests a possible link between EBV activation and the severity of fatigue experienced.
Why It Matters
This early Japanese study provides evidence that EBV reactivation may play a role in at least some CFS cases, supporting the hypothesis that viral factors contribute to disease pathogenesis. Understanding potential triggers could inform future diagnostic approaches and targeted interventions for ME/CFS patients.
Observed Findings
0.86% of screened patients (10/1,153) met definite CFS criteria
Definite CFS cases had significantly higher EA-IgG titers than probable cases and controls
EA-IgG/EBNA ratio ranged from low values to 16.0 in the highest case
The EA-IgG/EBNA ratio generally correlated with degree of fatigue severity
Other patients with chronic fatigue but not meeting CFS criteria (probable cases) had intermediate EBV antibody levels
Inferred Conclusions
A relationship exists between CFS and EBV activation
EA-IgG/EBNA ratio may serve as a marker of EBV activation status in CFS patients
EBV-related immune activation may be associated with fatigue severity
EBV should be investigated as a potential contributing factor in CFS etiology
Remaining Questions
Does EBV activation cause CFS or is it an epiphenomenon of the disease?
Can the EA-IgG/EBNA ratio be used as a diagnostic or prognostic tool in larger, prospective studies?
What This Study Does Not Prove
This study does not prove that EBV causes CFS—it shows correlation, not causation. The small sample size (10 definite cases) and observational design limit generalizability. The study does not determine whether elevated EBV antibodies are a cause, consequence, or coincidental finding in CFS.